Insider Transactions in Q3 2022 at Karuna Therapeutics, Inc. (KRTX)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2022
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,500
-12.24%
|
$2,404,500
$229.01 P/Share
|
|
Sep 09
2022
|
Stephen K. Brannan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-25.0%
|
$1,215,000
$243.46 P/Share
|
|
Sep 09
2022
|
Stephen K. Brannan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+20.0%
|
$35,000
$7.27 P/Share
|
|
Aug 15
2022
|
Laurie J Olson |
SELL
Open market or private sale
|
Direct |
1,000
-100.0%
|
$267,000
$267.59 P/Share
|
|
Aug 15
2022
|
Laurie J Olson |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+50.0%
|
$84,000
$84.86 P/Share
|
|
Aug 09
2022
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
16,500
-39.79%
|
$3,745,500
$227.83 P/Share
|
|
Aug 09
2022
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,500
+28.46%
|
$148,500
$9.2 P/Share
|
|
Aug 09
2022
|
Stephen K. Brannan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
25,000
-34.82%
|
$5,700,000
$228.09 P/Share
|
|
Aug 09
2022
|
Stephen K. Brannan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+25.61%
|
$175,000
$7.91 P/Share
|
|
Aug 05
2022
|
James Healy |
BUY
Exercise of conversion of derivative security
|
Direct |
32,500
+50.0%
|
$520,000
$16.0 P/Share
|
|
Jul 11
2022
|
Stephen K. Brannan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,000
-50.0%
|
$1,995,000
$133.29 P/Share
|
|
Jul 11
2022
|
Stephen K. Brannan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+33.33%
|
$135,000
$9.2 P/Share
|